Founder of CardioGene Therapeutics, Inc., Jeffrey M. Leiden is a businessperson who has been the head of 8 different companies and currently is Chairman of PathAI, Inc. and Executive Chairman at Vertex Pharmaceuticals, Inc.

He is also Member of Association of American Physicians, Member of American Society of Clinical Investigation, Member of National Academy of Medicine of United States, Member of Institute of Medicine and Member of American Academy of Arts & Sciences and on the board of 6 other companies.

In his past career Jeffrey M. Leiden occupied the position of Chairman of Lycera Corp., President & Chief Operating Officer of Abbott Laboratories, Chairman at Variation Biotechnologies (US), Inc., Chairman of TYRX, Inc., Managing Director at Clarus Ventures LLC, President & Chief Operating Officer of Pharmaceutical Products, Member of National Heart, Lung & Blood Institute, Professor at Harvard Medical School, Professor-Biological Sciences at Harvard T.H. Chan School of Public Health and Professor-Medicine & Pathology at The University of Chicago.

Jeffrey M. Leiden received a doctorate and an undergraduate degree from The University of Chicago.